The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
I do so want to get back in but I still feel that the Mcap is still ahead of the game I have set my buy price and will live in hope.............lets face it this is a great company and if proven I am proven wrong I can always buy in at a higher price when I am happier to pay the sp of the day.
Davethedumplin, I was just thinking the same, I don't mind just as long as it is after the results
my guess is that if successful they might need it for distribution logistic purposes.
Of course someone might want a slice of the action and provide the necessary funds.
Assuming a green light on the vote the company is funded for 18 months.
The company can concentrate on :-
Fitting out the factory Finding new collaborations Researching new products
Major negative impacts:-
CD19 in general CD is disrupting general hospital work so orders are delayed until..
Looking Forward...............crystal ball gazing
For those holding a long term view.....ignore the next few weeks......a profitable future awaits.
For those with a view to day trading..........concentrate.......a profitable future awaits
My crystal ball is available for hire................good luck all
Good morning hamilton, your comment " If people buy or sell it affects the sp." That's only true if the MM's want it to - I have seem many shares that have had several days of steady buying or selling and the share price has not moved at all......much to my frustration!
Cheers TOB
Forest24
Synairgen has paused the SG015 trial of SNG001 (inhaled interferon-beta 1a)
in COPD patients due to the prevalence of COVID-19 in the community, with
109 out of 120 patients recruited. The Company has received approval from
the Medicines and Healthcare products Regulatory Agency (MHRA) to conduct
an unplanned interim analysis on the grounds that data from the 109 COPD
patients with confirmed viral infection generates useful safety, biomarker and
potentially efficacy data to support ongoing trials of SNG001 in COVID-19
patients. The results of this interim analysis are expected this Summer.
Treetop, Exposure? It doesn't need or want exposure, it has approval to trial it's product, those that will buy it are paying attention.........................it may yet fail............but for all our sakes lets hope it works.
Cheers tOB
Sonnets and StuoftheToon, Had to trawl back a ways to find what the Question was !
Email last night confirming subscription........"Once the Offer has been completed and publicly announced, all investors will be notified of their allocation of shares. In the event of a scale back, we will refund any excess funds to you within 5 working days. Please check our FAQs for more information." My guess you will get what you asked for..........sounds more like a treat Haha
The timing of this information ......words fail me.
If it wasn't for this BB I and many others have missed it
I really think that we should act as one voice and communicate the appalling manner that this information was conveyed to shareholders.
I will write in the morning explaining my feeling does anyone wish to join me?
I thought that they were such a brilliant outfit......how wrong can you be!
Welcome Timely_Tim
Para 1. No Dividends
Absolutely normal this is the AIM market where ideas are turned into success or failure, they burn up money at an alarming rate often calling on shareholders for more and more money.
AFC. One step forward two steps back.
I agree but that hasn't stopped me making money. But and here is the catch if all the promises or just some come true AFC SP will go like a Hydrogen rocket.
Portfolio.
Some good names there.
Advice?
I don't give any but try and take a balanced view, I only invest what I can truly lose - (not that I want too). I Try and research companies I take punt or invest in. I invest for the long term but take advantage of opportunities.
Hope my words have been of value. Cheers TOB
Take care be safe Covid 19 hasn't finished with us yet. Thank you Carers all.
Morning all, in regard to UK gov funding ( and German gov) I have written twice to the company about this but sadly have not received a reply, as I remember a fellow poster did at the time say " good luck with that".......he wasn't wrong!
Stay safe all.
The last time we enjoyed this sort of volume was 12th Feb when the SP was 22
The SP continued to rise for 6 days and peaked at 33 (volume 36M)
It then gradually declined until the 8th May funding support at SP12.8
Will history repeat itself or has a deal been struck or a sale made?